跳转至内容
Merck
CN

T1063

Sigma-Aldrich

Thrombin 来源于人类血浆

lyophilized powder, ≥2800 NIH units/mg protein (E1%/280, 18.3)

别名:

IIa因子

登录查看公司和协议定价


About This Item

CAS号:
EC 号:
MDL编号:
UNSPSC代码:
12352204
NACRES:
NA.54

表单

lyophilized powder

质量水平

比活

≥2800 NIH units/mg protein (E1%/280, 18.3)

分子量

37.4 kDa

杂质

HIV, hepatitis B and hepatitis C, tested negative

UniProt登记号

应用

diagnostic assay manufacturing

储存温度

−20°C

基因信息

human ... F2(2147)

正在寻找类似产品? 访问 产品对比指南

一般描述

凝血酶是止血过程中的最终凝血蛋白酶,可同时促进促凝血和抗凝血作用。

应用

凝血酶被用于重组融合蛋白的位点特异性切割,这些重组融合蛋白具有可接近的凝血酶识别位点以除去亲和标签。凝血酶已可用于评估低分子量肝素在 体外 对肝硬化患者在肝病不同阶段的凝血酶生成的影响。

生化/生理作用

选择性裂解纤维蛋白原中 Arg-Gly 键形成纤维蛋白和纤维蛋白肽 A 和 B 的丝氨酸蛋白酶。

单位定义

活性以NIH单位表示,它是通过与NIH凝血酶参考标准品直接对比而获得的

外形

冻干品来自于0.02 M Bis/Tris缓冲液,pH 6.5,含0.15M氯化钠和0.1% PEG-8000

分析说明

NIH 试验步骤基于 Biggs 方法的改进,使用 0.2mL 稀释血浆(与生理盐水 1:1 混合,作为底物)和 0.1mL Biggs 凝血酶样品(稳定于 1% 缓冲白蛋白溶液中)。只使用 15-25 秒之间的凝血时间分析凝血酶浓度。

其他说明

免责声明

供研究使用。在法国,在用于科研目的时(包括进口和出口活动(《公共健康法》第L 1211-1条,第2节))该产品为管制品。购买者(即最终用户)需要获得《公共健康法》法第L 1211-1条规定的法国研究部的进口授权。订购本产品即表明您确认已经获得合适的进口授权。

象形图

Health hazardExclamation mark

警示用语:

Danger

危险分类

Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - STOT SE 3

靶器官

Respiratory system

储存分类代码

11 - Combustible Solids

WGK

WGK 2

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

高风险级别生物产品--人源产品

从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Zhong Feng Gao et al.
Nature protocols, 15(2), 316-337 (2020-01-10)
Current visual biosensing methods, including colorimetric-based, fluorescence-based and chemiluminescence-based methods, are inappropriate for the hundreds of millions of people affected by color blindness and color weakness. Compared with these available methods, a droplet motion-based strategy might be a promising protocol
Sooyeon Kim et al.
RSC advances, 8(37), 20822-20828 (2018-06-06)
We propose a new sensor design that maximizes fluorescence contrast, inspired by whispering-gallery mode lasing (WGM). Aptamer-modified glass microspheres (cf. 1-38 μm) and thrombin are used as a model sensory cavity and target protein, respectively. Two types of microsphere are
D David et al.
British journal of haematology, 113(3), 604-615 (2001-05-31)
In haemophilia A, the functional defect at the molecular level of most factor VIII (FVIII) missense mutations remains unknown. Site-directed mutagenesis of B domain-deleted FVIII cDNA (FVIIISQ) was used to introduce two mutations associated with severe cross-reacting material (CRM)-negative (FVIII-C329S)
M Senzolo et al.
Journal of thrombosis and haemostasis : JTH, 10(9), 1823-1829 (2012-06-21)
Cirrhotic patients may present thrombotic complications that warrant anticoagulant therapy. However, the efficacy of low-molecular-weight heparin (LMWH) in this clinical setting is still unclear. To evaluate the in vitro effect of LMWH on thrombin generation (TG) in cirrhotic patients at
Giselle Barbosa-Lima et al.
Journal of leukocyte biology, 108(4), 1293-1306 (2020-07-15)
Dengue is characterized as one of the most important arthropod-borne human viral diseases, representing a public health problem. Increased activation of immune cells is involved in the progression of infection to severe forms. Recently, our group demonstrated the contribution of

商品

Thrombin Factor IIa is an endolytic serine protease that selectively cleaves the Arg--Gly bonds of fibrinogen to form fibrin and release fibrinopeptides A and B.

凝血酶因子IIa是一种内切丝氨酸蛋白酶,可选择性地裂解纤维蛋白原的Arg -Gly键,形成纤维蛋白并释放纤维蛋白肽A和B。

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门